• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YANG Qingjuan,WU Hongxi.Microenvironmental regulation of macrophage metabolic reprogramming in liver disease and targeted therapeutic strategies[J].Journal Of Pharmaceutical Research,2026,45(7):796-805[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 954times   Download 559次 QR Code for this article
Scan with your phone!
肝脏疾病微环境对巨噬细胞代谢重编程的调控与靶向治疗策略
杨庆涓,吴红茜
Font:Larger+|Default|Smaller-
(中国药科大学药学院,江苏 南京 211198)
摘要:
肝脏疾病与免疫调节异常及代谢功能障碍密切相关。巨噬细胞作为核心免疫细胞,其功能受代谢重编程精准调控,并推动疾病沿“急性损伤-慢性炎症-纤维化-肝癌”进程演进。然而,疾病不同阶段的特征性微环境如何通过巨噬细胞代谢重编程调控其表型与疾病转归,目前仍缺乏系统阐释。基于此,本文重点探讨不同阶段肝脏病理微环境如何通过影响巨噬细胞代谢途径,调控其促炎与抗炎表型平衡,进而决定疾病进展或修复结局;并总结目前靶向巨噬细胞代谢重编程的治疗策略,以期为代谢导向的肝脏疾病治疗提供理论依据。
关键词:  肝脏疾病  巨噬细胞  代谢重编程  免疫代谢  炎症  抗肿瘤免疫
DOI:10.13506/j.cnki.jpr.2026.07.012
基金项目:国家自然科学基金项目(No.82273968)
Received Date:January 19, 2026   Revision Date:March 02, 2026   Publication Date:July 31, 2026
Microenvironmental regulation of macrophage metabolic reprogramming in liver disease and targeted therapeutic strategies
YANG Qingjuan,WU Hongxi
(School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Liver diseases closely link to immune dysregulation and metabolic dysfunction. Macrophages, serving as central immune effector cells, dynamically adjust their metabolic programs to control functional responses, thereby propelling pathological progression through sequential stages of acute injury, chronic inflammation, fibrosis, and hepatocellular carcinoma. However, a systematic understanding of how stage-specific microenvironment regulates macrophage phenotypes and clinical outcome via metabolic reprogramming remains incomplete. Therefore, this review systematically examined how the pathological microenvironment at different disease stages influences macrophage metabolism, thereby modulating the balance between pro-inflammatory and anti-inflammatory phenotypes and ultimately shaping disease progression or repair. Furthermore, current therapeutic strategies targeting macrophage metabolic reprogramming were summarized, to provide a theoretical basis for developing metabolism-guided treatments for liver diseases.
Key words:  Liver diseases  Macrophages  Metabolic reprogramming  Immunometabolism  Inflammatory  Antitumor immunity
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.